BioRestorative Therapies (BRTX) Change in Cash (2010 - 2025)
BioRestorative Therapies' (BRTX) quarterly Change in Cash came in at $908744.0 in Q4 2025, up 196.52% YoY from $306474.5 in Q4 2024, and up 195.38% on a QoQ basis from -$952807.0 in Q3 2025.
BioRestorative Therapies (BRTX) Change in Cash (2010 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 16 years of Change in Cash data on file, last reported at $908744.0 in Q4 2025.
- Quarterly Change in Cash rose 196.52% year-over-year to $908744.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $963298.0 (up 386.28% YoY) and the FY2025 annual result came in at $963298.0, up 386.28% from the prior year.
- Change in Cash improved to $908744.0 in Q4 2025, from -$952807.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $19.9 million in Q4 2021 to a low of -$11.4 million in Q3 2022.
- A 5-year average of -$77671.1 and a median of -$596532.5 in 2021 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2021 — Change in Cash tumbled 18190.53% — and 2024, when it soared 2173.28%.
- Tracing BRTX's Change in Cash over 5 years: stood at $19.9 million in 2021, then tumbled by 124.42% to -$4.9 million in 2022, then soared by 67.29% to -$1.6 million in 2023, then jumped by 40.77% to -$941554.0 in 2024, then soared by 196.52% to $908744.0 in 2025.
- The last three Change in Cash figures came in at $908744.0 (Q4 2025), -$952807.0 (Q3 2025), and $326462.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 | 908,744.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 908,744.00 |
| Sep 30, 2025 | -952,807.00 |
| Jun 30, 2025 | 326,462.00 |
| Mar 31, 2025 | 680,899.00 |
| Dec 31, 2024 | -941,554.00 |
| Sep 30, 2024 | -762,803.00 |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 272,703.00 |
| Dec 31, 2023 | -1.59 Mn |
| Sep 30, 2023 | 653,223.00 |
| Jun 30, 2023 | -52,823.00 |
| Mar 31, 2023 | 159,892.00 |
| Dec 31, 2022 | -4.86 Mn |
| Sep 30, 2022 | -11.36 Mn |
| Jun 30, 2022 | -1.39 Mn |
| Mar 31, 2022 | -1.70 Mn |
| Dec 31, 2021 | 19.90 Mn |
| Sep 30, 2021 | -629,364.00 |
| Jun 30, 2021 | -741,829.00 |
| Mar 31, 2021 | -563,701.00 |